Chinese Traditional and Herbal Drugs
|
2025, 56(12): 4289-4305
Mechanism of Jinzhen Oral Liquid on ameliorating lower respiratory tract infections-related inflammation and immune dysregulation based on systems pharmacology and transcriptome analysis
Full
LI Meiyao1, YANG Wanting1, GAO Yan1, YANG Yubing1, WANG Lei1, DONG Jiayu1, DING Mengjiao1, CAO Liang1, WANG Tuanjie1, WU Ziyin1, XIAO Wei1
Affiliations
1 State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture (Jiangsu Kanion Pharmaceutical Co., Ltd. &
doi: 10.7501/j.issn.0253-2670.2025.12.013
Outline
Objective To investigate the mechanism of Jinzhen Oral Liquid (金振口服液, JZ) on ameliorating inflammation and immune dysregulation related to lower respiratory tract infections (LRTIs) using an integrated approach combining systems pharmacology, transcriptomics, molecular docking and experimental validation. Methods Active components of JZ were screened using TCMSP database. Potential targets were predicted using SysDT algorithm. A herb-component-target network was constructed to identify core targets, followed by gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analyses using Metascape. Molecular docking was performed to key active components and herb targets using AutoDock software. Differentially expressed genes (DEGs) in peripheral blood mononuclear cells from LRTIs patients were integrated with JZ-predicted targets to identify overlapping targets for functional analysis. A model of human monocyte inflammation induced by lipopolysaccharide and γ interferon was constructed, and transcriptome sequencing was performed after the intervention of JZ (0.67, 1.34, 2.68 mg/mL). The expressions of core targets was verified using qRT-PCR and flow cytometry. Results A total of 34 active components and 210 potential targets were identified, of which 83 immune-related targets were significantly enriched in the tumor necrosis factor (TNF) and interleukin-17 (IL-17) signaling pathways (P < 0.05). A total of 294 LRTIs-related DEGs were intersected with JZ targets to obtain 11 key genes, involved in viral infection, TNF and IL-17 signaling pathways (P < 0.05). The monocyte inflammation model successfully recapitulated 66% of clinical DEGs. Low-, medium-, and high-doses of JZ restored 76.4%, 83.1% and 88.7% of dysregulated gene expression, respectively, modulating pathways including TNF and nuclear factor-κB (NF-κB). qRT-PCR demonstrated that JZ dose-dependently down-regulated TNF, IL-6 and chemokine ligand 2 mRNA expressions (P < 0.05, 0.01, 0.001), and significantly up-regulated the mRNA expressions of matrix metalloproteinase 9 and SMAD3 (P < 0.01, 0.001). Flow cytometry confirmed JZ reduced CD86⁺ M1 macrophage proportion and TNF-α secretion (P < 0.05, 0.01). Conclusion JZ exerts anti-LRTIs effects by synergistically regulating TNF, NF-κB and IL-17 signaling pathways through multiple targets to alleviate inflammatory symptoms and remodel immune homeostasis.
Jinzhen Oral Liquid
/
lower respiratory tract infections
/
systems pharmacology
/
transcriptomics
/
anti-inflammatory
/
immune regulation
李美瑶, 杨婉婷, 高燕, 杨钰冰, 王磊, 董佳裕, 丁梦娇, 曹亮, 王团结, 武子寅, 肖伟.
基于系统药理学和转录组学探讨金振口服液改善下呼吸道感染相关炎症及免疫紊乱的作用机制.
中草药,
2025
, 56
(12)
: 4289
-4305
.
DOI: 10.7501/j.issn.0253-2670.2025.12.013
LI Meiyao, YANG Wanting, GAO Yan, YANG Yubing, WANG Lei, DONG Jiayu, DING Mengjiao, CAO Liang, WANG Tuanjie, WU Ziyin, XIAO Wei.
Mechanism of Jinzhen Oral Liquid on ameliorating lower respiratory tract infections-related inflammation and immune dysregulation based on systems pharmacology and transcriptome analysis[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(12)
: 4289
-4305
.
DOI: 10.7501/j.issn.0253-2670.2025.12.013
Year 2025 volume 56 Issue 12
46
9
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.12.013
- Receive Date:2025-03-24
- Online Date:2026-11-13